Health and Fitness Health and Fitness
Tue, March 1, 2011
[ Tue, Mar 01st 2011 ] - Market Wire
eHealthInsurance Releases Tips
[ Tue, Mar 01st 2011 ] - Market Wire
NXP Strengthens Management Team
Mon, February 28, 2011

Somaxon Pharmaceuticals to Present at Upcoming Investor Conferences


Published on 2011-02-28 13:20:14 - Market Wire
  Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxona™s president and chief executive officer, is scheduled to present at the following investor conferences:

  • Monday, March 7, 2011
    Cowen and Company 31st Annual Health Care Conference
    The Boston Marriott Copley Place a" Boston, MA
    4:00 p.m. ET (1:00 p.m. PT)
  • Monday, March 14, 2011
    Roth 23rd Annual OC Growth Stock Conference
    The Ritz Carlton a" Laguna Niguel, CA
    12:30 p.m. ET (9:30 a.m. PT)
  • Wednesday, March 16, 2011
    Barclays Capital 2011 Global Healthcare Conference
    Loews Miami Beach Hotel a" Miami, FL
    3:45 p.m. ET (12:45 p.m. PT)

A live webcast of each presentation will be available in the Investor Relations section of the companya™s Web site under Event Scheduler at [ www.somaxon.com ]. Each webcast will be accessible following conclusion of the live event and archived for approximately 90 days.

To be added to Somaxon Pharmaceuticalsa™ email list, please visit [ http://bit.ly/Somaxon-email-list ].

About Somaxon Pharmaceuticals, Inc.

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxona™s product Silenor®, now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.

For more information, please visit the companya™s web site at [ www.somaxon.com ].